loadpatents
Patent applications and USPTO patent grants for Prendergast; George C..The latest application filed is for "scar reducing wound closure materials".
Patent | Date |
---|---|
Methods and compositions for the treatment of ocular diseases and disorders Grant 11,447,568 - Bravo-Nuevo , et al. September 20, 2 | 2022-09-20 |
Scar Reducing Wound Closure Materials App 20220176011 - Heber-Katz; Ellen ;   et al. | 2022-06-09 |
Methods and compositions for the treatment of diseases and disorders Grant 11,345,747 - Sunil , et al. May 31, 2 | 2022-05-31 |
Methods and Compositions for the Treatment of Autoimmune and Inflammatory Diseases App 20210040230 - Laury-Kleintop; Lisa ;   et al. | 2021-02-11 |
Methods And Compositions For The Treatment Of Cancer App 20200261414 - Muller; Alexander J. ;   et al. | 2020-08-20 |
Compositions Comprising Ligands To Rhob Protein And The Uses Thereof App 20200200760 - Laury-Kleintop; Lisa ;   et al. | 2020-06-25 |
Methods And Compositions For The Treatment Of Diseases And Disorders App 20200157199 - Sunil; Thomas ;   et al. | 2020-05-21 |
Methods and compositions for the treatment of diseases and disorders Grant 10,494,424 - Thomas , et al. De | 2019-12-03 |
Methods and Compositions for the Treatment of Immunomodulatory Diseases and Disorders App 20190062452 - Laury-Kleintop; Lisa ;   et al. | 2019-02-28 |
Methods and Compositions for the Treatment of Autoimmune and Inflammatory Diseases App 20180094076 - Laury-Kleintop; Lisa ;   et al. | 2018-04-05 |
Anti-RhoB antibodies Grant 9,879,092 - Laury-Kleintop , et al. January 30, 2 | 2018-01-30 |
Methods and Compositions for the Treatment of Diseases and Disorders App 20180009882 - Thomas; Sunil ;   et al. | 2018-01-11 |
Methods and Compositions for the Treatment of Ocular Diseases and Disorders App 20170190789 - Bravo-Nuevo; Arturo ;   et al. | 2017-07-06 |
Anti-Tissue Inhibitor of Metalloproteinase-4 (Timp-4) Antibodies and Methods of Use Thereof App 20170008975 - Wallon; U. Margaretha ;   et al. | 2017-01-12 |
Disulfide chemotherapeutic agents and methods of use thereof Grant 9,522,164 - Ayene , et al. December 20, 2 | 2016-12-20 |
Methods And Compositions For The Treatment Of Autoimmune And Inflammatory Diseases App 20140227279 - Laury-Kleintop; Lisa ;   et al. | 2014-08-14 |
Disulfide Chemotherapeutic Agents and Methods of Use Thereof App 20140079812 - Ayene; Iraimoudi S. ;   et al. | 2014-03-20 |
Disulfide chemotherapeutic agents and methods of use thereof Grant 8,586,636 - Ayene , et al. November 19, 2 | 2013-11-19 |
Indoleamine 2,3-Dioxygenase-2 App 20130227719 - Prendergast; George C. ;   et al. | 2013-08-29 |
Novel IDO Inhibitors and Methods of Use Thereof App 20130183388 - Prendergast; George C. ;   et al. | 2013-07-18 |
IDO inhibitors and methods of use Grant 8,476,454 - Prendergast , et al. July 2, 2 | 2013-07-02 |
Indoleamine 2,3-dioxygenase-2 antibodies Grant 8,436,151 - Prendergast , et al. May 7, 2 | 2013-05-07 |
IDO inhibitors and methods of use thereof Grant 8,389,568 - Prendergast , et al. March 5, 2 | 2013-03-05 |
Methods for the treatment of cancer Grant 8,383,613 - Prendergast , et al. February 26, 2 | 2013-02-26 |
Indoleamine 2,3-Dioxygenase-2 App 20120090044 - Prendergast; George C. ;   et al. | 2012-04-12 |
Novel Methods for the Treatment of Cancer App 20110311648 - Prendergast; George C. ;   et al. | 2011-12-22 |
Nucleic acid molecules encoding indoleamine 2,3-dioxygenase-2 Grant 8,058,416 - Prendergast , et al. November 15, 2 | 2011-11-15 |
Methods for the treatment of cancer Grant 8,008,281 - Prendergast , et al. August 30, 2 | 2011-08-30 |
Novel Ido Inhibitors And Methods Of Use App 20100233166 - Prendergast; George C. ;   et al. | 2010-09-16 |
Novel IDO Inhibitors and Methods of Use Thereof App 20100166881 - Prendergast; George C. ;   et al. | 2010-07-01 |
IDO inhibitors and methods of use Grant 7,714,139 - Prendergast , et al. May 11, 2 | 2010-05-11 |
IDO inhibitors and methods of use thereof Grant 7,705,022 - Prendergast , et al. April 27, 2 | 2010-04-27 |
Novel IDO Inhibitors and Methods of Use Thereof App 20100076066 - Prendergast; George C. ;   et al. | 2010-03-25 |
Indoleamine 2,3-Dioxygenase-2 App 20090158451 - Prendergast; George C. ;   et al. | 2009-06-18 |
"Novel ido inhibitors and methods of use App 20070173524 - Prendergast; George C. ;   et al. | 2007-07-26 |
Novel IDO inhibitors and methods of use thereof App 20070105907 - Prendergast; George C. ;   et al. | 2007-05-10 |
Novel methods for the treatment of cancer App 20070099844 - Prendergast; George C. ;   et al. | 2007-05-03 |
Bridging INtegrator-2 (Bin2) nucleic acid molecules and proteins and uses therefor Grant 7,150,968 - Prendergast , et al. December 19, 2 | 2006-12-19 |
Method of treating cancer Grant 6,989,383 - Rosen , et al. January 24, 2 | 2006-01-24 |
Bridging integrator-2 (Bin2) nucleic acid molecules and proteins and uses therefor App 20050214798 - Prendergast, George C. ;   et al. | 2005-09-29 |
Bridging Integrator-2(Bin2) nucleic acid molecules and proteins and uses therefor Grant 6,831,063 - Prendergast , et al. December 14, 2 | 2004-12-14 |
Box-dependent Myc-interacting protein (BIN1) compositions and uses therefor App 20030166021 - Prendergast, George C. ;   et al. | 2003-09-04 |
Murine and human box-dependent myc-interacting protein (Bin1) and uses therefor Grant 6,048,702 - Prendergast , et al. April 11, 2 | 2000-04-11 |
Murine and human c-Myc interacting protein Grant 5,605,830 - Prendergast , et al. February 25, 1 | 1997-02-25 |
NCAGE Code | 485B9 | PRENDERGAST GEORGE C |
CAGE Code | 485B9 | PRENDERGAST, GEORGE C |
DUNS | 611652665 | PRENDERGAST, GEORGE C |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.